Bevacizumab/cisplatin/pemetrexedVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1807卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79328-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：42 / 42

相关论文

共 50 条

[31] PemetrexedVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1767 (1) : 259 - 259
[32] PemetrexedVarious toxicities: 5 case reports
Reactions Weekly, 2024, 2039 (1) : 469 - 469
[33] PemetrexedVarious toxicities: 13 case reports
Reactions Weekly, 2025, 2047 (1) : 371 - 371
[34] PemetrexedVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1699 (1) : 246 - 246
[35] PemetrexedVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1877 (1) : 330 - 330
[36] Bevacizumab/cisplatin/cyclophosphamideVarious toxicities: 7 case reports
Reactions Weekly, 2023, 1968 (1) : 72 - 72
[37] Bevacizumab/cisplatin/paclitaxelVarious toxicities: 6 case reports
Reactions Weekly, 2020, 1813 (1) : 62 - 62
[38] Bevacizumab/cisplatin/gemcitabineVarious toxicities: 13 case reports
Reactions Weekly, 2016, 1583 (1) : 203 - 203
[39] Bevacizumab/oxaliplatinVarious toxicities: case report
Reactions Weekly, 2020, 1809 (1) : 68 - 68
[40] Bevacizumab/capecitabineVarious toxicities: case report
Reactions Weekly, 2019, 1750 (1) : 62 - 62

← 1 2 3 4 5 →